Evidence map›Paper›PMID 41973696›Full record

ArticlePloS one2026

Use of administrative data for evaluating trends in medically-attended Lyme disease, Manitoba, Canada, 2010-2021.

Maria Major, Susan Horton, Natalie Nightingale, Kate Halsby, Frederick J Angulo, James Stark, Holly Yu, Mark Loeb, Irene Wang, Saranya Nair and 6 more

Abstract read
In one paragraph

Article in PloS one, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Maria MajorPfizer, Kirkland, Quebec, Canada.ORCID https://orcid.org/0000-0003-3719-7225
Susan HortonUniversity of Waterloo, Waterloo, Ontario, Canada.ORCID https://orcid.org/0000-0002-9243-4767
Natalie NightingaleIQVIA, Mississauga, Ontario, Canada.
Kate HalsbyPfizer, Tadworth, United Kingdom.
Frederick J AnguloPfizer, New York, New York, United States of America.
James StarkPfizer, Cambridge, Massachusetts, United States of America.
Holly YuPfizer, Collegeville, Pennsylvania, United States of America.
Mark LoebMcMaster University, Hamilton, Ontario, Canada.
Irene WangIQVIA, Mississauga, Ontario, Canada.
Saranya NairIQVIA, Mississauga, Ontario, Canada.
Calum S NeishIQVIA, Mississauga, Ontario, Canada.
Doneal ThomasIQVIA, Mississauga, Ontario, Canada.
Chloe McDonaldPfizer, Kirkland, Quebec, Canada.
Samuel Torres-FlorezPfizer, Kirkland, Quebec, Canada.ORCID https://orcid.org/0000-0002-0590-4282
Ana G GrajalesPfizer, Kirkland, Quebec, Canada.
Sarah J WillisPfizer, Cambridge, Massachusetts, United States of America.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

While Lyme disease (LD) is the most common tick-borne disease reported to public health surveillance in North America and is increasingly recognized as a public health threat in Canada, it's incidence may be underreported. Our study aims to estimate medically-attended LD incidence in Manitoba, Canada, using administrative health data. We identified medically-attended LD cases in Manitoba from 2010 - 2021 in a claims database (Manitoba Population Research Data Repository), which contains the health records of >95% of the residents of Manitoba, using diagnostic codes, antibiotic dispensations, and laboratory results. The incidence of claims-based LD cases ranged from 8.4 to 28.5 per 100,000 population per year, 5.1 to 11.0 times higher than the incidence of surveillance-reported LD cases. The incidence of claims-based LD cases was particularly higher than the incidence of surveillance-reported LD cases in females and health regions with a low surveillance-reported incidence. Our study suggests that medically attended LD is more common than reported in surveillance. Further study is required to identify barriers to reporting. Interventions are needed to reduce the substantial burden of LD in Manitoba.

Indexed as

Lyme DiseaseAdolescentAdultAgedChildDatabases, FactualFemaleHumansIncidenceMaleManitobaMiddle AgedYoung Adult

Identifiers

PMID41973696
PMCPMC13075671

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.